VEGFA and hepatocellular carcinoma: Contrary to our study, Kawaguchi et al. reported that serum levels of VEGF in patients who were treated with DAAs were elevated during treatment and maintained a high level until 12 weeks after treatment, and these patients developed rapidly growing HCC [23].